Vimarsana
Biggest News Aggregation in the World

Page 2 - Enzymatica Ab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Enzymatica Ab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Enzymatica Ab Today - Breaking & Trending Today

Interim report from clinical study: ColdZyme significantly reduces rhinovirus viral load and symptoms of sore throat - Vimarsana News

Interim report from clinical study: ColdZyme significantly reduces rhinovirus viral load and symptoms of sore throat

/PRNewswire/ -- The first results from an ongoing independent clinical study at the University of Kent, UK, show that ColdZyme® significantly reduces the viral...

Interim report Q1/2023: Strong start to the year - Enzymatica's growth journey continues according to plan - Vimarsana News

Interim report Q1/2023: Strong start to the year - Enzymatica's growth journey continues according to plan

/PRNewswire/ -- First quarter Net sales reached SEK 13.0 (4.2) million. The operating result totaled SEK -14.4 (-18.1) million. Earnings per share, basic and...

Enzymatica AB: Interim report Q4/2022: A year that laid the foundation for growth - Vimarsana News

Enzymatica AB: Interim report Q4/2022: A year that laid the foundation for growth

/PRNewswire/ -- Significant events during the quarter Significant events after the quarter On October 31, the journal Respiratory Research published an...

Enzymatica AB Interim report Q3/2022: A broader role for ColdZyme adds potential for the future - Vimarsana News

Enzymatica AB Interim report Q3/2022: A broader role for ColdZyme adds potential for the future

/PRNewswire/ -- Significant events during the quarter Significant events after the quarter · To ensure the long-term financing of the business, in September...

Related Topics:
Enzymatica Ab
Enzymatica publishes supplementary prospectus - Vimarsana News

Enzymatica publishes supplementary prospectus

/PRNewswire/ -- The Board of Directors of Enzymatica AB ("Enzymatica" or "Company") has issued a supplement (the "Supplementary Prospectus") in addition to the...